Open AccessHuman Immunoglobulin (KIOVIG ® /GAMMAGARD LIQUID ® ) for Immunodeficiency and Autoimmune Diseases: An Observational Cohort Study
Author(s) -
Bohumír Blažek,
Siraj Misbah,
Pere SolerPalacín,
Barbara McCoy,
Heinz Leibl,
Werner Engl,
Victoria Empson,
David Gelmont,
Nikolai Nikolov
Publication year - 2015
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt.15.30
Subject(s) - antibody , medicine , immunodeficiency , immunology , cohort , autoimmune disease , human immunodeficiency virus (hiv) , primary immunodeficiency , virology , immune system
To document the therapeutic efficacy and safety of Human Normal Immunoglobulin 10% Liquid (KIOVIG(®)/GAMMAGARD LIQUID(®) [IVIG 10%]) under clinical routine conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom